Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 0 | 0 | 69 | 0 | 0 |
| Gross Profit | N/A | N/A | 69 | N/A | N/A |
| Operating Expenses | 30,691 | 22,484 | 25,355 | 0 | 0 |
| Operating Income | -30,691 | -22,484 | -25,286 | N/A | N/A |
| Interest Expense | 236 | 155 | 0 | 0 | 0 |
| Other Income | 2,475 | -11,441 | 7,765 | 0 | 0 |
| Pre-tax Income | -28,452 | -34,081 | -17,521 | 0 | 0 |
| Net Income Continuous | -28,452 | -34,081 | -17,521 | N/A | N/A |
| Net Income Discontinuous | -3,348 | -5,049 | N/A | N/A | N/A |
| Net Income | $-31,800 | $-39,130 | $-17,521 | $N/A | $N/A |
| EPS Basic Total Ops | -171.43 | -360.39 | -0.95 | N/A | N/A |
| EPS Basic Continuous Ops | -153.40 | -313.64 | -0.96 | N/A | N/A |
| EPS Basic Discontinuous Ops | -18.05 | -46.46 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -171.43 | -360.39 | -0.95 | N/A | N/A |
| EPS Diluted Continuous Ops | -153.40 | -313.64 | -0.96 | N/A | N/A |
| EPS Diluted Discontinuous Ops | -18.05 | -46.46 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -142.86 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-26,791 | $-20,541 | $-25,145 | $N/A | $N/A |